{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:23:30Z","timestamp":1773833010802,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,14]]},"DOI":"10.7759\/cureus.48793","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T15:17:33Z","timestamp":1699975053000},"source":"Crossref","is-referenced-by-count":3,"title":["The Relationship Between C-Reactive Protein (CRP) Concentrations and Erythropoietin Resistance, Hospital Admission Rate, Control of Mineral Metabolism, and Comorbidity in Hemodialysis Patients"],"prefix":"10.7759","author":[{"given":"Reema","family":"Alsogair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifa A","family":"Altoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meznah","family":"Alsanad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malak","family":"Alshukr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bashayer","family":"AlObaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulla","family":"Al Sayyari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mubarak","family":"Abdalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kisu.2017.04.001","article-title":"KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone\u00a0Disorder (CKD-MBD)","volume":"7","year":"2017","unstructured":"KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone\u00a0Disorder (CKD-MBD). Kidney Int Suppl. 2017, 7.1-59. 10.1016\/j.kisu.2017.04.001","journal-title":"Kidney Int Suppl"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","unstructured":"Global, regional, and national burden of chronic kidney disease, 1990-2017. a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020, 395:709-33. 10.1016\/S0140-6736(20)30045-3","journal-title":"Lancet"},{"key":"ref3","unstructured":"Saudi Center for Organ Transplantation. Annual Report for Organ Transplantation in Kingdom of Saudi Arabia. (2019). Accessed. June 4, 2023: https:\/\/ghdx.healthdata.org\/organizations\/saudi-center-organ-transplantation."},{"key":"ref4","article-title":"C-reactive protein and other markers of inflammation in hemodialysis patients","volume":"4","author":"Heidari B","year":"2013","unstructured":"Heidari B. C-reactive protein and other markers of inflammation in hemodialysis patients . Caspian J Intern Med. 2013, 4:611-6.","journal-title":"Caspian J Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006080926","article-title":"Inflammatory syndrome in patients on hemodialysis","volume":"17","author":"Jofr\u00e9 R","year":"2006","unstructured":"Jofr\u00e9 R, Rodriguez-Benitez P, L\u00f3pez-G\u00f3mez JM, P\u00e9rez-Garcia R. Inflammatory syndrome in patients on hemodialysis. J Am Soc Nephrol. 2006, 17:S274-80. 10.1681\/ASN.2006080926","journal-title":"J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.18632\/aging.102046","article-title":"The interplay between mineral metabolism, vascular calcification and inflammation in chronic kidney disease (CKD): challenging old concepts with new facts","volume":"11","author":"Viegas C","year":"2019","unstructured":"Viegas C, Ara\u00fajo N, Marreiros C, Simes D. The interplay between mineral metabolism, vascular calcification and inflammation in chronic kidney disease (CKD): challenging old concepts with new facts. Aging (Albany NY). 2019, 11:4274-99. 10.18632\/aging.102046","journal-title":"Aging (Albany NY)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8065691","article-title":"Factors Influencing hemoglobin variability and its association with mortality in hemodialysis patients","volume":"2018","author":"Bal Z","year":"2018","unstructured":"Bal Z, Demirci BG, Karakose S, Tutal E, Erkmen Uyar M, Acar NO, Sezer S. Factors Influencing hemoglobin variability and its association with mortality in hemodialysis patients. Sci World J. 2018, 2018:8065691. 10.1155\/2018\/8065691","journal-title":"Sci World J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2020.01.007","article-title":"Inflammation and erythropoiesis-stimulating agent response in hemodialysis patients: a self-matched longitudinal study of anemia management in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"2","author":"Karaboyas A","year":"2020","unstructured":"Karaboyas A, Morgenstern H, Fleischer NL, et al.. Inflammation and erythropoiesis-stimulating agent response in hemodialysis patients: a self-matched longitudinal study of anemia management in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Kidney Med. 2020, 2:286-96. 10.1016\/j.xkme.2020.01.007","journal-title":"Kidney Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-019-02250-x","article-title":"The relationship between vitamin D and inflammatory markers in maintenance hemodialysis patients","volume":"51","author":"Kara AV","year":"2019","unstructured":"Kara AV, Soylu YE. The relationship between vitamin D and inflammatory markers in maintenance hemodialysis patients. Int Urol Nephrol. 2019, 51:1659-65. 10.1007\/s11255-019-02250-x","journal-title":"Int Urol Nephrol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.261329","article-title":"Vascular calcification in patients with chronic kidney disease on dialysis in the Kingdom of Saudi Arabia: a cross-sectional study","volume":"30","author":"AlGhonaim MA","year":"2019","unstructured":"AlGhonaim MA, Fathalla AA. Vascular calcification in patients with chronic kidney disease on dialysis in the Kingdom of Saudi Arabia: a cross-sectional study. Saudi J Kidney Dis Transpl. 2019, 30:571-80. 10.4103\/1319-2442.261329","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-019-01685-8","article-title":"Altered mineral metabolism and disequilibrium between calcification promoters and inhibitors in chronic hemodialysis patients","volume":"193","author":"Wang CL","year":"2020","unstructured":"Wang CL, Lin KP, Hsu GW, Liu KL, Guo CH. Altered mineral metabolism and disequilibrium between calcification promoters and inhibitors in chronic hemodialysis patients. Biol Trace Elem Res. 2020, 193:14-22. 10.1007\/s12011-019-01685-8","journal-title":"Biol Trace Elem Res"},{"key":"ref12","article-title":"Contribution of inflammation to vascular disease in chronic kidney disease patients","volume":"19","author":"Suliman ME","year":"2008","unstructured":"Suliman ME, Stenvinkel P. Contribution of inflammation to vascular disease in chronic kidney disease patients. Saudi J Kidney Dis Transpl. 2008, 19:329-45.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56615-4","article-title":"Inflammation as a predictor of acute kidney injury and mediator of higher mortality after acute kidney injury in non-cardiac surgery","volume":"9","author":"Murashima M","year":"2019","unstructured":"Murashima M, Nishimoto M, Kokubu M, et al.. Inflammation as a predictor of acute kidney injury and mediator of higher mortality after acute kidney injury in non-cardiac surgery. Sci Rep. 2019, 9:20260. 10.1038\/s41598-019-56615-4","journal-title":"Sci Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07110711","article-title":"Dialysis modality and outcomes in kidney transplant recipients","volume":"7","author":"Molnar MZ","year":"2012","unstructured":"Molnar MZ, Mehrotra R, Duong U, et al.. Dialysis modality and outcomes in kidney transplant recipients. Clin J Am Soc Nephrol. 2012, 7:332-41. 10.2215\/CJN.07110711","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00031.2016","article-title":"Role of the immune system in hypertension","volume":"97","author":"Rodriguez-Iturbe B","year":"2017","unstructured":"Rodriguez-Iturbe B, Pons H, Johnson RJ. Role of the immune system in hypertension. Physiol Rev. 2017, 97:1127-64. 10.1152\/physrev.00031.2016","journal-title":"Physiol Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2017\/26595.10456","article-title":"Hypertension, C reactive protein and metabolic profile: what is the scenario in patients undergoing arteriography?","volume":"11","author":"Tofano RJ","year":"2017","unstructured":"Tofano RJ, Barbalho SM, Bechara MD, Quesada K, Mendes CG, Oshiiwa M. Hypertension, C reactive protein and metabolic profile: what is the scenario in patients undergoing arteriography?. J Clin Diagn Res. 2017, 11:BC19-23. 10.7860\/JCDR\/2017\/26595.10456","journal-title":"J Clin Diagn Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000160351.95181.d0","article-title":"Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality","volume":"25","author":"Davey Smith G","year":"2005","unstructured":"Davey Smith G, Lawlor DA, Harbord R, et al.. Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality. Arterioscler Thromb Vasc Biol. 2005, 25:1051-6. 10.1161\/01.ATV.0000160351.95181.d0","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.160130","article-title":"Comparison of C-reactive protein levels with delivered dose of Kt\/V in patients with end-stage renal disease on maintenance hemodialysis","volume":"26","author":"Rashid H","year":"2015","unstructured":"Rashid H. Comparison of C-reactive protein levels with delivered dose of Kt\/V in patients with end-stage renal disease on maintenance hemodialysis. Saudi J Kidney Dis Transpl. 2015, 26:692-6. 10.4103\/1319-2442.160130","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.4103\/mmj.mmj_591_17","article-title":"C-reactive protein as a marker of pediatric hemodialysis adequacy","volume":"32","author":"El-Mashad GM","year":"2019","unstructured":"El-Mashad GM, El-Gebally ES, Afifi TH. C-reactive protein as a marker of pediatric hemodialysis adequacy. Menoufia Med J. 2019, 32:323-8. 10.4103\/mmj.mmj_591_17","journal-title":"Menoufia Med J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.12145","article-title":"The level of C-reactive protein in chronic hemodialysis patients: a comparative study between patients with noninfected catheters and arteriovenous fistula in two large Gulf hemodialysis centers","volume":"18","author":"Sabry AA","year":"2014","unstructured":"Sabry AA, Elshafey EM, Alsaran K, Shalaby M, Alsherbeiny S, Abdelkader M. The level of C-reactive protein in chronic hemodialysis patients: a comparative study between patients with noninfected catheters and arteriovenous fistula in two large Gulf hemodialysis centers. Hemodial Int. 2014, 18:674-9. 10.1111\/hdi.12145","journal-title":"Hemodial Int"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2014.07.010","article-title":"Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study","volume":"64","author":"Banerjee T","year":"2014","unstructured":"Banerjee T, Kim SJ, Astor B, Shafi T, Coresh J, Powe NR. Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis. 2014, 64:954-61. 10.1053\/j.ajkd.2014.07.010","journal-title":"Am J Kidney Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1177\/2054358116669129","article-title":"Hemodialysis tunneled catheter-related infections","volume":"3","author":"Miller LM","year":"2016","unstructured":"Miller LM, Clark E, Dipchand C, et al.. Hemodialysis tunneled catheter-related infections. Can J Kidney Health Dis. 2016, 3:2054358116669129. 10.1177\/2054358116669129","journal-title":"Can J Kidney Health Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1590\/s0100-879x2005000500017","article-title":"Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients","volume":"38","author":"Nascimento MM","year":"2005","unstructured":"Nascimento MM, Bruchfeld A, Suliman ME, et al.. Effect of hepatitis C serology on C-reactive protein in a cohort of Brazilian hemodialysis patients. Braz J Med Biol Res. 2005, 38:783-8. 10.1590\/s0100-879x2005000500017","journal-title":"Braz J Med Biol Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1590\/0037-8682-0455-2018","article-title":"Association of serum levels of C-reactive protein with CRP-717 T\/C polymorphism and viremia in HCV and HBV carriers","volume":"52","author":"Moura TC","year":"2019","unstructured":"Moura TC, Amoras ED, Queiroz MA, Conde SR, Gris\u00f3lia AB, Ishak R, Vallinoto AC. Association of serum levels of C-reactive protein with CRP-717 T\/C polymorphism and viremia in HCV and HBV carriers. Rev Soc Bras Med Trop. 2019, 52:e20180455. 10.1590\/0037-8682-0455-2018","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/nu5031002","article-title":"Mineral metabolic abnormalities and mortality in dialysis patients","volume":"5","author":"Abe M","year":"2013","unstructured":"Abe M, Okada K, Soma M. Mineral metabolic abnormalities and mortality in dialysis patients. Nutrients. 2013, 5:1002-23. 10.3390\/nu5031002","journal-title":"Nutrients"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh732","article-title":"Mineral metabolism and haemoglobin concentration among haemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"20","author":"Kimata N","year":"2005","unstructured":"Kimata N, Akiba T, Pisoni RL, et al.. Mineral metabolism and haemoglobin concentration among haemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant. 2005, 20:927-35. 10.1093\/ndt\/gfh732","journal-title":"Nephrol Dial Transplant"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1027230","article-title":"High erythropoiesis resistance index is a significant predictor of cardiovascular and all-cause mortality in Chinese maintenance hemodialysis patients","volume":"2020","author":"Lu X","year":"2020","unstructured":"Lu X, Zhang J, Wang S, Yu Q, Li H. High erythropoiesis resistance index is a significant predictor of cardiovascular and all-cause mortality in Chinese maintenance hemodialysis patients. Mediators Inflamm. 2020, 2020:1027230. 10.1155\/2020\/1027230","journal-title":"Mediators Inflamm"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.07.014","article-title":"Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis","volume":"61","author":"Koulouridis I","year":"2013","unstructured":"Koulouridis I, Alfayez M, Trikalinos TA, Balk EM, Jaber BL. Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis. Am J Kidney Dis. 2013, 61:44-56. 10.1053\/j.ajkd.2012.07.014","journal-title":"Am J Kidney Dis"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1201","article-title":"Progression of left ventricular diastolic dysfunction and risk of heart failure","volume":"306","author":"Kane GC","year":"2011","unstructured":"Kane GC, Karon BL, Mahoney DW, et al.. Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA. 2011, 306:856-63. 10.1001\/jama.2011.1201","journal-title":"JAMA"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124772","article-title":"Association between inflammation and cardiac geometry in chronic kidney disease: findings from the CRIC study","volume":"10","author":"Gupta J","year":"2015","unstructured":"Gupta J, Dominic EA, Fink JC, et al.. Association between inflammation and cardiac geometry in chronic kidney disease: findings from the CRIC study. PLoS One. 2015, 10:e0124772. 10.1371\/journal.pone.0124772","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/182627-the-relationship-between-c-reactive-protein-crp-concentrations-and-erythropoietin-resistance-hospital-admission-rate-control-of-mineral-metabolism-and-comorbidity-in-hemodialysis-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:59Z","timestamp":1707508499000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/182627-the-relationship-between-c-reactive-protein-crp-concentrations-and-erythropoietin-resistance-hospital-admission-rate-control-of-mineral-metabolism-and-comorbidity-in-hemodialysis-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,14]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.48793","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,14]]}}}